Implication of green tea as a possible therapeutic approach for Parkinson disease

Juan C. Jurado-Coronel, Marco Ávila-Rodriguez, Valentina Echeverria, Oscar Alejandro Hidalgo, Janneth Gonzalez, Gjumrakch Aliev, George E. Barreto

Research output: Contribution to journalArticlepeer-review

Abstract

Green tea is a beverage consumed around the world that is believed to have substantial health benefits such as reducing the risk of cancer, cardiovascular diseases, diabetes and neurodegeneration. This beverage is prepared from the leaves (steamed and dried) of the Camellia sinesis plant and contains strong antioxidant and neuroprotective phenolic compounds from which the most important is (-)-Epigallocatechin-3-gallate. Parkinson’s disease (PD) is the second more common neurodegenerative disorders, after Alzheimer’s disease and is characterized by degeneration of dopaminergic neurons in the pars compact of the substantia nigra of the basal ganglia. It has been shown in pre-clinical and clinical studies that green tea may be able to prevent PD, but its optimal dose or a possible mechanism explaining its health benefit in PD has not been properly established. In this review, we discuss the potential role of green tea’s phenolic compounds and their therapeutic effectin modulating key signaling pathways in the PD brain.

Original languageEnglish
Pages (from-to)292-300
Number of pages9
JournalCNS and Neurological Disorders - Drug Targets
Volume15
Issue number3
DOIs
Publication statusPublished - 1 Apr 2016
Externally publishedYes

Keywords

  • (-)-epigallocatechin-3-gallate
  • Antioxidant
  • Green tea
  • Neuroprotection
  • Oxidative stress
  • Parkinson disease

Fingerprint

Dive into the research topics of 'Implication of green tea as a possible therapeutic approach for Parkinson disease'. Together they form a unique fingerprint.

Cite this